Sean P. Lyden, MD
Print Faculty Schedule:
|
SCHEDULE FOR VEITHsymposium™ |
Wednesday, November 16, 2022 |
Presenter
Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With Fempop Lesions At 5 Years In The ILLUMENATE US And European RCTs: There Was No Paclitaxel Mortality Signal
10:24 AM - 10:29 AM
|
Presenter
Percutaneous (PQ) Transvenous Fempop PTFE Bypasses With The Torus 2 Device (Now From Endologix): How It Works And Status Of The DETOUR And TORUS Trials In The US: 1-Year Results
2:36 PM - 2:41 PM
|
Thursday, November 17, 2022 |
Presenter
Alto Endograft (From Endologix) For Standard EVAR: This Latest Modification Of The Ovation Endograft Has More Proximal Polymer Sealing Rings: Results From The ELEVATE Trial And 3-4-Year Results From The New Zealand Experience Show Advantages: What Is The JAGUAR RCT
8:14 AM - 8:19 AM
|
Presenter
Why Ruby Coils, The Penumbra Occlusion Device (POD) And Packing Coils Have Different Uses And Why They Are Valuable And Cost Effective For Different Lesions: Technical Tips For Optimizing
5:12 PM - 5:17 PM
|
Saturday, November 19, 2022 |
ASSOCIATE FACULTY SCHEDULE FOR VEITHsymposium™ |
Friday, November 18, 2022 |
Moderator
|
previous | next |